Ranbaxy Laboratories (Delisted) financials and balance sheet
BSE: 500359
Last traded ₹859.80 on 1 Apr 2015
Delisted on 30 Mar 2016.
6 years at a glance
Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to December.Ranbaxy Laboratories annual reports
Revenue, net profit and borrowings, ₹ crore
- Revenue
- Net profit
- Borrowings
- Loss
A loss in 3 of the 6 years shown
Operating and net margin, per cent
- Operating marginOperating margin. Operating profit before depreciation as a percentage of revenue: how much of each rupee of sales is left after running costs.
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
The years either side of a change of basis do not compare. From the year to Dec 2008, the company's revenue for that year, ₹4,472 Cr, differs from its quarters added, ₹4,350 Cr.
Results for the year to Dec 2012
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
From revenue to net profit
- Revenue6,304
- Other income+240
- One-off items−381
- Finance costs−297
- Profit before tax−164
- Tax+1.9
- Net profit−162
Profit and loss
Standalone, ₹ crore, years to December.Ranbaxy Laboratories quarterly results
| ₹ crore | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 |
|---|---|---|---|---|---|---|
| Revenue from operations | 4,034 | 4,472 | 4,783 | 5,672 | 7,690 | 6,304 |
| Operating expenses. What the business spent to run itself in the period, materials, staff and other costs, before depreciation, interest and tax. | – | – | – | – | – | – |
| Materials and goods boughtCost of materials and goods. Raw materials used and goods bought for resale in the period, adjusted for the change in stock held. | 1,526 | 421 | 446 | 491 | 501 | 2,288 |
| Other incomeOther income. Income from outside the main business, such as interest on deposits, dividends received and gains on investments. | 341 | 210 | 276 | 360 | 346 | 240 |
| Finance costsFinance costs. Interest and the other costs of borrowing in the period. | 92 | 893 | −110 | 54 | 604 | 297 |
| Profit before one-off items and taxProfit before one-off items and tax. Profit before tax as it would be without the one-off items below it, as the company states it. | – | −1,619 | 1,062 | 1,311 | 724 | 217 |
| One-off itemsExceptional items. Gains or losses the company reports separately because they are not expected to recur, such as selling a business or writing down an asset. | 36 | – | – | 255 | −3,772 | −381 |
| Profit before tax | 782 | −1,619 | 1,062 | 1,565 | −3,049 | −164 |
| Tax | 159 | −574 | 490 | 417 | 3 | −2 |
| Net profit | 623 | −1,045 | 572 | 1,149 | −3,052 | −162 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 15.4% | −23.4% | 12.0% | 20.3% | −39.7% | −2.6% |
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Dec 2007, Dec 2008, Dec 2009, Dec 2010, Dec 2011 and Dec 2012: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given.
Ratios
Standalone, years to December.
| Ratio | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 |
|---|---|---|---|---|
| Revenue growthRevenue growth. This year's revenue less last year's, divided by last year's, times 100; blank where last year's is not above nought. | 6.9% | 18.6% | 35.6% | −18.0% |
| Net profit growthNet profit growth. This year's net profit less last year's, divided by last year's, times 100; blank where last year's is not above nought. | – | 100.8% | – | – |
| Earnings per share growthEarnings per share growth. This year's earnings per share less last year's, on the same share count, divided by last year's, times 100; blank where last year's is not above nought. | – | 100.6% | – | – |
Revenue growth is left blank for the year to Dec 2008: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out.
Growth and returns over 3, 5 and 10 years
Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Dec 2012.
| Measure | 5 years | 3 years |
|---|---|---|
| Revenue growth, yearly rateRevenue growth, yearly rate. 3 years: Revenue in the latest year ÷ revenue in the year three years before, to the power of one third, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 5 years: Revenue in the latest year ÷ revenue in the year five years before, to the power of one fifth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 10 years: Revenue in the latest year ÷ revenue in the year ten years before, to the power of one tenth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. | 9.3% | 9.6% |
| Net margin, averageNet margin, average. 3 years: The plain average of the yearly net profit margin over the last three years, needing at least two of them; a year without the figure is left out, never filled in. 5 years: The plain average of the yearly net profit margin over the last five years, needing at least four of them; a year without the figure is left out, never filled in. 10 years: The plain average of the yearly net profit margin over the last ten years, needing at least nine of them; a year without the figure is left out, never filled in. | −6.7% | −7.3% |
Accounting checks
Standalone, years to December. Published tests of whether reported profit is backed by cash and the balance sheet.
| Check | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 |
|---|---|---|---|---|
| Effective tax rateEffective tax rate. Tax charged as a percentage of profit before tax.Published threshold 17.16 per cent | 46.14 | 26.61 | – | – |
A threshold marked as ours has no published figure; it is the line we read the check against.